Author:
Saad Abdalla Al-Zawi Abdalla,Yin Su-Lei,Mahmood Bayan,Jalil Awais,Aladili Zina
Reference30 articles.
1. The Oncotype DX assay in ER-positive, HER2-negative breast cancer patients: a real life experience from a single cancer center;Thibodeau S;Eur J Breast Health,2019
2. Relationship of Oncotype DX score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi population;Durrani S;Ann Diagn Pathol,2021
3. The Oncotype DX Recurrence Score impact on the management of ER-positive, HER2-negative, node-negative breast cancer;Saad Abdalla Al-Zawi A;Med Res J,2021
4. Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use;Schaafsma E;Breast Cancer Res,2021
5. Benefits of introduction of Oncotype DX® testing;Green N;Ann R Coll Surg Engl,2019
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献